Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.
about
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.Epigenetic Regulation of Interleukin 6 by Histone Acetylation in Macrophages and Its Role in Paraquat-Induced Pulmonary Fibrosis.Panobinostat for the treatment of acute myelogenous leukemia.
P2860
Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.
@en
type
label
Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.
@en
prefLabel
Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.
@en
P2860
P50
P356
P1433
P1476
Overview of Histone Deacetylase Inhibitors in Haematological Malignancies.
@en
P2093
H Miles Prince
Michael Dickinson
P2860
P304
P356
10.3390/PH3082674
P577
2010-08-17T00:00:00Z